(Q33370834)

26 July 2017

Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia (English)

1 reference

26 July 2017

Rafael Fonseca

2

0 references

Angela Dispenzieri

object named as

Angela Dispenzieri

12

0 references

Robert A Kyle

16

object named as

Robert A Kyle

1 reference

26 July 2017

11

Martha Q Lacy

1 reference

26 July 2017

13

S Vincent Rajkumar

1 reference

26 July 2017

3

Morie A Gertz

1 reference

26 July 2017

9

John A Lust

1 reference

26 July 2017

10

Thomas E Witzig

1 reference

26 July 2017

5

Dirk R Larson

1 reference

26 July 2017

4

Matthew F Plevak

1 reference

26 July 2017

1

Irene M Ghobrial

1 reference

26 July 2017

15

Philip R Greipp

1 reference

26 July 2017

14

Stephen R Zeldenrust

1 reference

26 July 2017

Terry M Therneau

6

1 reference

26 July 2017

Robert C Wolf

7

1 reference

26 July 2017

Randi J Hoffmann

8

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

British Journal of Haematology

26 July 2017

1 reference

26 July 2017

133

1 reference

26 July 2017

158-164

1 reference

26 July 2017

2

1 reference

Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003).

26 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06003.X

The international staging system for multiple myeloma is applicable in symptomatic Waldenstrom's macroglobulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06003.X

Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06003.X

Waldenström macroglobulinaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06003.X

Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06003.X

Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06003.X

Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06003.X

Prognostic factors in symptomatic Waldenstrom's macroglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06003.X

10.1111/J.1365-2141.2006.06003.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference